Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updated: Revision changed from v3.0.1 to v3.0.2, signaling a minor update. Also removed the 'Back to Top' link; no changes to pricing, stock, or time-sensitive information.
    Difference
    0.2%
    Check dated 2025-09-13T17:44:32.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:27:57.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated to include new medical topics related to oral cancer and specific treatment methods, while removing several outdated terms and classifications related to neoplasms and cancer treatments.
    Difference
    4%
    Check dated 2025-08-30T12:14:10.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now indicates that results have been submitted, replacing the previous message that no results were posted.
    Difference
    0.1%
    Check dated 2025-08-23T08:10:06.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:51:43.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T00:16:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.